MCENANY PATRICK J
Insider CIK 929985 · CPRX President and CEO, Director, 10% owner · KOOL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 10,540 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,552 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,534 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 34,921 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 43,591 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 73,810 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 272,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 270,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 400,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 740,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 4,171,559 | $31.50 | $131.40M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 26,334 | — | $0 | 1,851,948 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-29 | 2025-12-30 | 6,786 | — | $0 | 4,171,559 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 26,334 | — | $0 | 4,178,345 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 3,534 | — | $0 | 1,878,282 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 3,534 | — | $0 | 4,152,011 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | G Gift | 2025-12-01 | 2025-12-03 | 45,000 | — | $0 | 4,328,477 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | G Gift | 2025-12-01 | 2025-12-03 | 45,000 | — | $0 | 4,193,477 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | G Gift | 2025-12-01 | 2025-12-03 | 45,000 | — | $0 | 4,148,477 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 1,775 | — | $0 | 1,881,816 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 1,775 | — | $0 | 4,283,477 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 10,540 | — | $0 | 1,883,591 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 34,921 | — | $0 | 1,873,051 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-06-09 | 2025-06-10 | 171,748 | $26.11 | $4.48M | 4,281,702 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-06-06 | 2025-06-10 | 28,252 | $25.95 | $733.1K | 4,453,450 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 3,533 | — | $0 | 1,838,130 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 3,533 | — | $0 | 4,481,702 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 5,327 | — | $0 | 1,841,663 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 43,591 | — | $0 | 1,836,336 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-20 | 2024-11-21 | 72,500 | — | $0 | 1,792,745 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-20 | 2024-11-21 | 72,500 | $3.54 | $256.6K | 4,550,669 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-20 | 2024-11-21 | 72,500 | $21.29 | $1.54M | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-19 | 2024-11-21 | 98,345 | — | $0 | 1,865,245 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-19 | 2024-11-21 | 98,345 | $21.19 | $2.08M | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-19 | 2024-11-21 | 98,345 | $3.54 | $348.1K | 4,576,514 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-14 | 2024-11-15 | 44,655 | — | $0 | 1,963,590 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-14 | 2024-11-15 | 44,655 | $21.75 | $971.2K | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-14 | 2024-11-15 | 44,655 | $3.54 | $158.1K | 4,522,824 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-13 | 2024-11-15 | 92,500 | — | $0 | 2,008,245 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-13 | 2024-11-15 | 92,500 | $3.54 | $327.4K | 4,570,669 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-13 | 2024-11-15 | 92,500 | $22.98 | $2.13M | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-12 | 2024-11-13 | 70,000 | — | $0 | 2,292,745 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-12 | 2024-11-13 | 192,000 | — | $0 | 2,100,745 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-12 | 2024-11-13 | 70,000 | $4.01 | $280.7K | 4,548,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-12 | 2024-11-13 | 70,000 | $23.42 | $1.64M | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-12 | 2024-11-13 | 192,000 | $3.54 | $679.7K | 4,670,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-12 | 2024-11-13 | 192,000 | $23.20 | $4.45M | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-11 | 2024-11-13 | 230,000 | — | $0 | 2,362,745 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-11 | 2024-11-13 | 230,000 | $4.01 | $922.3K | 4,708,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-11 | 2024-11-13 | 230,000 | $23.55 | $5.42M | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | G Gift | 2024-08-22 | 2024-08-26 | 5,100 | — | $0 | 4,478,169 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | G Gift | 2024-08-15 | 2024-08-19 | 45,000 | — | $0 | 4,483,269 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-01-30 | 2024-01-31 | 116,667 | — | $0 | 2,592,745 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-01-30 | 2024-01-31 | 26,333 | — | $0 | 2,709,412 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-01-30 | 2024-01-31 | 116,667 | — | $0 | 4,528,256 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-01-30 | 2024-01-31 | 26,333 | — | $0 | 4,411,589 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-01-02 | 2024-01-03 | 250,000 | — | $0 | 2,735,745 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-01-02 | 2024-01-03 | 250,000 | $1.13 | $282.5K | 4,385,256 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 26,333 | — | $0 | 2,985,745 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 26,333 | — | $0 | 4,145,618 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-12-27 | 2023-12-29 | 10,362 | — | $0 | 4,135,256 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 73,810 | — | $0 | 3,001,477 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 10,601 | — | $0 | 3,012,078 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-05-16 | 2023-05-17 | 173,849 | — | $0 | 2,927,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-05-16 | 2023-05-17 | 173,849 | $0.79 | $137.3K | 4,119,285 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-05-15 | 2023-05-17 | 26,151 | — | $0 | 3,101,516 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-05-15 | 2023-05-17 | 26,151 | $0.79 | $20.7K | 3,971,587 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-05-15 | 2023-05-17 | 26,151 | $13.23 | $346.0K | 3,945,436 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 58,333 | — | $0 | 3,127,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 58,333 | — | $0 | 3,959,640 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-02-15 | 2023-02-17 | 14,204 | — | $0 | 3,945,436 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | G Gift | 2022-12-29 | 2022-12-30 | 10,000 | — | $0 | 3,901,307 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | G Gift | 2022-12-28 | 2022-12-30 | 10,000 | — | $0 | 3,911,307 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 79,000 | — | $0 | 3,186,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 272,000 | — | $0 | 3,107,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 30,834 | — | $0 | 2,835,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2022-12-06 | 2022-12-08 | 12,133 | — | $0 | 3,921,307 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 30,834 | — | $0 | 3,933,440 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-11-21 | 2022-11-22 | 150,000 | — | $0 | 2,865,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-11-21 | 2022-11-22 | 150,000 | $2.24 | $336.0K | 4,052,606 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-21 | 2022-11-22 | 150,000 | $15.33 | $2.30M | 3,902,606 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-11-18 | 2022-11-22 | 350,000 | — | $0 | 3,015,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-11-18 | 2022-11-22 | 350,000 | $2.24 | $784.0K | 4,252,606 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-18 | 2022-11-22 | 350,000 | $15.62 | $5.47M | 3,902,606 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-14 | 2022-09-15 | 946,846 | $15.41 | $14.59M | 3,902,606 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-13 | 2022-09-15 | 80,765 | $15.33 | $1.24M | 4,849,452 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-19 | 2022-08-19 | 125,000 | — | $0 | 3,365,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-19 | 2022-08-19 | 125,000 | $14.10 | $1.76M | 4,930,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-19 | 2022-08-19 | 125,000 | $2.53 | $316.3K | 5,055,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-18 | 2022-08-19 | 50,000 | — | $0 | 3,490,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-18 | 2022-08-19 | 25,000 | — | $0 | 3,640,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-18 | 2022-08-19 | 50,000 | — | $0 | 3,590,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-18 | 2022-08-19 | 50,000 | — | $0 | 3,540,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-18 | 2022-08-19 | 50,000 | $13.95 | $697.5K | 4,930,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 50,000 | $2.53 | $126.5K | 4,980,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-18 | 2022-08-19 | 50,000 | $13.96 | $698.0K | 4,930,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 50,000 | $2.53 | $126.5K | 4,980,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-18 | 2022-08-19 | 50,000 | $13.93 | $696.5K | 4,930,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 50,000 | $2.53 | $126.5K | 4,980,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-18 | 2022-08-19 | 25,000 | $13.93 | $348.3K | 4,930,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 25,000 | $2.53 | $63.2K | 4,955,217 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 175,000 | — | $0 | 3,665,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 270,000 | — | $0 | 3,490,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 30,833 | — | $0 | 3,220,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2021-12-03 | 2021-12-06 | 12,132 | — | $0 | 4,930,227 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 30,833 | — | $0 | 4,942,359 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-08-23 | 2021-08-24 | 120,000 | — | $0 | 3,251,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-23 | 2021-08-24 | 120,000 | $3.12 | $374.4K | 4,994,143 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-23 | 2021-08-24 | 82,617 | $5.63 | $465.1K | 4,911,526 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-08-20 | 2021-08-24 | 80,000 | — | $0 | 3,371,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-20 | 2021-08-24 | 80,000 | $3.12 | $249.6K | 4,928,304 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-20 | 2021-08-24 | 54,161 | $5.52 | $299.0K | 4,874,143 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-08-13 | 2021-08-17 | 100,000 | — | $0 | 3,451,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-13 | 2021-08-17 | 31,529 | $6.07 | $191.4K | 4,848,304 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-13 | 2021-08-17 | 31,186 | $6.17 | $192.4K | 4,879,833 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-13 | 2021-08-17 | 100,000 | $3.12 | $312.0K | 4,911,019 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 400,000 | — | $0 | 3,551,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2020-12-22 | 2020-12-28 | 30,833 | — | $0 | 3,151,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-28 | 30,833 | — | $0 | 4,818,526 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2020-12-22 | 2020-12-28 | 7,507 | — | $0 | 4,811,019 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2020-09-30 | 2020-09-30 | 15,000 | $2.97 | $44.5K | 4,787,693 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 740,000 | — | $0 | 3,090,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 92,500 | — | $0 | 3,182,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2019-10-03 | 2019-10-03 | 10,000 | $4.89 | $48.9K | 4,772,693 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2019-06-11 | 2019-06-11 | 25,000 | $3.23 | $80.8K | 4,762,693 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 166,667 | — | $0 | 2,183,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 166,667 | — | $0 | 2,350,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 166,666 | — | $0 | 2,016,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-12-19 | 2018-12-19 | 20,000 | $2.24 | $44.8K | 4,737,693 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-05-29 | 2018-05-31 | 166,667 | — | $0 | 1,850,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-05-29 | 2018-05-31 | 166,667 | — | $0 | 1,683,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-05-29 | 2018-05-31 | 166,666 | — | $0 | 1,516,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-04-03 | 2018-04-03 | 20,000 | $2.29 | $45.8K | 4,717,693 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 100,000 | — | $0 | 1,250,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 100,000 | — | $0 | 1,150,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 100,000 | — | $0 | 1,350,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2017-11-13 | 2017-11-14 | 26,667 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-11-13 | 2017-11-14 | 26,667 | — | $0 | 4,697,693 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2017-11-06 | 2017-11-07 | 200,000 | — | $0 | 500,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-11-06 | 2017-11-07 | 200,000 | $0.47 | $94.0K | 4,671,026 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2017-09-05 | 2017-09-05 | 20,000 | $2.58 | $51.6K | 4,471,026 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | X Exercise deriv | 2017-05-22 | 2017-05-22 | 31,250 | $0.80 | $25.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-05-22 | 2017-05-22 | 31,250 | $1.04 | $32.5K | 4,451,026 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 83,333 | — | $0 | 1,083,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 83,333 | — | $0 | 1,166,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 83,334 | — | $0 | 1,250,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2016-11-17 | 2016-11-18 | 26,667 | — | $0 | 26,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2016-11-17 | 2016-11-18 | 26,667 | — | $0 | 4,419,776 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 100,000 | — | $0 | 1,100,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 100,000 | — | $0 | 1,000,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-06-14 | 2016-06-14 | 105,300 | $0.65 | $68.4K | 4,393,109 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-04-26 | 2016-04-26 | 50,000 | $0.65 | $32.5K | 4,287,809 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 100,000 | — | $0 | 900,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 100,000 | — | $0 | 800,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 100,000 | — | $0 | 700,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2015-12-28 | 2015-12-28 | 25,000 | $2.39 | $59.8K | 4,237,809 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2015-12-07 | 2015-12-07 | 26,666 | — | $0 | 53,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2015-12-07 | 2015-12-07 | 26,666 | — | $0 | 4,212,809 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2015-10-29 | 2015-10-30 | 75,000 | — | $0 | 600,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2015-10-29 | 2015-10-30 | 75,000 | $1.09 | $81.8K | 4,212,262 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2015-10-29 | 2015-10-30 | 26,119 | — | $0 | 4,186,143 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2015-10-01 | 2015-10-01 | 10,000 | $2.81 | $28.1K | 4,137,262 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-04-27 | 2015-04-27 | 5,000 | $3.79 | $18.9K | 4,127,262 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise deriv | 2015-02-25 | 2015-02-27 | 364,804 | — | $0 | 786,250 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise | 2015-02-25 | 2015-02-27 | 364,804 | $0.69 | $251.7K | 4,189,801 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | F Tax w/h | 2015-02-25 | 2015-02-27 | 67,539 | — | $0 | 4,122,262 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-01-08 | 2015-01-08 | 50,000 | $2.80 | $140.0K | 3,970,918 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-11-13 | 2014-11-17 | 26,666 | — | $0 | 1,097,720 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-11-13 | 2014-11-17 | 26,667 | — | $0 | 1,151,054 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-11-13 | 2014-11-17 | 26,667 | — | $0 | 1,124,387 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise deriv | 2014-10-02 | 2014-10-03 | 150,000 | — | $0 | 1,231,054 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise | 2014-10-02 | 2014-10-03 | 150,000 | $0.90 | $135.0K | 3,920,918 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-11-04 | 100,000 | — | $0 | 1,121,054 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-11-04 | 100,000 | — | $0 | 1,021,054 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-11-04 | 100,000 | — | $0 | 1,221,054 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 153,333 | — | $0 | 1,074,387 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 153,334 | — | $0 | 1,381,054 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 153,333 | — | $0 | 1,227,720 | SEC↗ |
| KOOL CESCA THERAPEUTICS INC. | A Award deriv | 2014-07-01 | 2014-07-02 | 25,000 | — | $0 | 122,750 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2014-05-21 | 2014-05-21 | 25,000 | $1.89 | $47.3K | 3,656,247 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2014-02-07 | 2014-02-07 | 25,000 | $1.82 | $45.5K | 3,631,247 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2013-10-21 | 2013-10-21 | 50,000 | $1.59 | $79.5K | 3,606,247 | SEC↗ |
| KOOL THERMOGENESIS CORP | A Award deriv | 2013-07-01 | 2013-07-02 | 15,000 | — | $0 | 109,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2013-02-19 | 2013-02-20 | 50,000 | $0.46 | $23.0K | 3,556,247 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-12-17 | 2012-12-18 | 100,000 | $0.45 | $45.0K | 3,449,997 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,667 | — | $0 | 869,387 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,667 | — | $0 | 936,054 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,666 | — | $0 | 802,720 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-11-15 | 2012-11-15 | 100,000 | $0.42 | $42.0K | 3,349,997 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-07-03 | 2012-07-03 | 700 | $0.54 | $378 | 3,249,997 | SEC↗ |
| KOOL THERMOGENESIS CORP | A Award deriv | 2012-07-02 | 2012-07-05 | 15,000 | — | $0 | 100,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-07-02 | 2012-07-03 | 30,500 | $0.54 | $16.5K | 3,249,297 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-05-30 | 2012-05-31 | 10,000 | $0.58 | $5.8K | 3,218,797 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy deriv | 2012-05-24 | 2012-05-29 | 31,250 | — | $0 | 1,009,191 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-05-24 | 2012-05-29 | 31,250 | $0.80 | $25.0K | 3,208,797 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-02-14 | 2012-02-14 | 1,600 | $1.10 | $1.8K | 3,179,147 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-02-14 | 2012-02-14 | 23,400 | $1.15 | $26.9K | 3,202,547 | SEC↗ |